Security key
59102M104
- Type / Class
- Equity / COM
- Total 13F shares
- 11,662,818
- Share change
- -548,323
- Total reported value
- $25,306,458
- Price per share
- $2.17
- Number of holders
- 65
- Value change
- -$3,651,260
- Number of buys
- 40
- Number of sells
- 20
Report period
Q3 2024
Institutions
65
Top holders
10
MGX full security history
Newer quarter: Q4 2024
Previous quarter: Q2 2024
Metagenomi Therapeutics, Inc. SEC filings
Metagenomi Therapeutics, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 59102M104
Recent filing periods:
Top shareholders of MGX - Metagenomi Therapeutics, Inc. - COM (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| BAYER HEALTHCARE LLC |
3/4/5
|
10%+ Owner |
—
class O/S missing
|
4,050,997
|
$11,666,871 | — | 13 Feb 2024 | |
| Novo Holdings A/S |
13F
3/4/5
|
Company · 10%+ Owner |
—
class O/S missing
|
1,800,000
|
$7,344,000 | — | 30 Jun 2024 | |
| Sebastian Bernales |
3/4/5
|
Director |
—
mixed-class rows
|
3,147,422
mixed-class rows
|
$6,620,950 | — | 01 Apr 2024 | |
| RA CAPITAL MANAGEMENT, L.P. |
13F
|
Company |
—
class O/S missing
|
1,477,749
|
$6,029,216 | — | 30 Jun 2024 | |
| FARALLON CAPITAL MANAGEMENT LLC |
13F
|
Company |
—
class O/S missing
|
1,343,201
|
$5,480,260 | — | 30 Jun 2024 | |
| PFM Health Sciences, LP |
13F
|
Company |
—
class O/S missing
|
1,267,002
|
$5,169,368 | — | 30 Jun 2024 | |
| HHLR ADVISORS, LTD. |
13F
|
Company |
—
class O/S missing
|
777,768
|
$3,173,293 | — | 30 Jun 2024 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
—
class O/S missing
|
729,852
|
$2,931,927 | — | 30 Jun 2024 | |
| EVENTIDE ASSET MANAGEMENT, LLC |
13F
|
Company |
—
class O/S missing
|
583,041
|
$2,378,808 | — | 30 Jun 2024 | |
| Sozo Ventures GP II, L.P. |
13F
|
Company |
—
class O/S missing
|
581,577
|
$2,372,834 | — | 30 Jun 2024 | |
| Deep Track Capital, LP |
13F
|
Company |
—
class O/S missing
|
466,232
|
$1,902,227 | — | 30 Jun 2024 | |
| BlackRock Finance, Inc. |
13F
|
Company |
—
class O/S missing
|
420,242
|
$1,714,587 | — | 30 Jun 2024 | |
| NORGES BANK |
13F
|
Company |
—
class O/S missing
|
360,202
|
$1,469,624 | — | 30 Jun 2024 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
—
class O/S missing
|
313,162
|
$1,228,692 | — | 30 Jun 2024 | |
| Artal Group S.A. |
13F
|
Company |
—
class O/S missing
|
300,000
|
$1,224,000 | — | 30 Jun 2024 | |
| PURA VIDA INVESTMENTS, LLC |
13F
|
Company |
—
class O/S missing
|
270,618
|
$1,038,964 | — | 30 Jun 2024 | |
| Frazier Life Sciences Management, L.P. |
13F
|
Company |
—
class O/S missing
|
245,692
|
$1,002,423 | — | 30 Jun 2024 | |
| VANGUARD GROUP INC |
13F
|
Company |
—
class O/S missing
|
216,166
|
$881,957 | — | 30 Jun 2024 | |
| ExodusPoint Capital Management, LP |
13F
|
Company |
—
class O/S missing
|
192,763
|
$786,000 | — | 30 Jun 2024 | |
| MARSHALL WACE, LLP |
13F
|
Company |
—
class O/S missing
|
168,639
|
$688,047 | — | 30 Jun 2024 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
—
class O/S missing
|
164,235
|
$670,077 | — | 30 Jun 2024 | |
| Point72 Asset Management, L.P. |
13F
|
Company |
—
class O/S missing
|
99,002
|
$403,927 | — | 30 Jun 2024 | |
| Simon Harnest |
3/4/5
|
Title: Chief Investment Officer and Senior Vice President of Strategy |
—
mixed-class rows
|
171,239
mixed-class rows
|
$353,272 | — | 01 Apr 2024 | |
| Simren Delaney |
3/4/5
|
Title: Vice President of Intellectual Property and Legal Operations |
—
mixed-class rows
|
123,037
mixed-class rows
|
$270,409 | — | 01 Apr 2024 | |
| Luis Borges |
3/4/5
|
Chief Scientific Officer |
—
mixed-class rows
|
360,766
mixed-class rows
|
$199,630 | — | 01 Apr 2024 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
—
class O/S missing
|
45,111
|
$184,053 | — | 30 Jun 2024 | |
| MORGAN STANLEY |
13F
|
Company |
—
class O/S missing
|
44,718
|
$182,449 | — | 30 Jun 2024 | |
| JACOBS LEVY EQUITY MANAGEMENT, INC |
13F
|
Company |
—
class O/S missing
|
44,156
|
$180,156 | — | 30 Jun 2024 | |
| TWO SIGMA INVESTMENTS, LP |
13F
|
Company |
—
class O/S missing
|
37,694
|
$153,792 | — | 30 Jun 2024 | |
| STATE STREET CORP |
13F
|
Company |
—
class O/S missing
|
30,474
|
$124,334 | — | 30 Jun 2024 | |
| NEW YORK STATE COMMON RETIREMENT FUND |
13F
|
Company |
—
class O/S missing
|
26,600
|
$108,528 | — | 30 Jun 2024 | |
| Resolute Advisors LLC |
13F
|
Company |
—
class O/S missing
|
26,500
|
$108,120 | — | 30 Jun 2024 | |
| WELLS FARGO & COMPANY/MN |
13F
|
Company |
—
class O/S missing
|
26,312
|
$107,352 | — | 30 Jun 2024 | |
| Hudson Bay Capital Management LP |
13F
|
Company |
—
class O/S missing
|
17,000
|
$69,360 | — | 30 Jun 2024 | |
| XTX Topco Ltd |
13F
|
Company |
—
class O/S missing
|
16,244
|
$66,276 | — | 30 Jun 2024 | |
| Bramshill Investments, LLC |
13F
|
Company |
—
class O/S missing
|
15,500
|
$63,240 | — | 30 Jun 2024 | |
| NORTHERN TRUST CORP |
13F
|
Company |
—
class O/S missing
|
13,596
|
$55,472 | — | 30 Jun 2024 | |
| Squarepoint Ops LLC |
13F
|
Company |
—
class O/S missing
|
10,202
|
$41,624 | — | 30 Jun 2024 | |
| Cerity Partners LLC |
13F
|
Company |
—
class O/S missing
|
10,000
|
$40,800 | — | 30 Jun 2024 | |
| RHUMBLINE ADVISERS |
13F
|
Company |
—
class O/S missing
|
6,423
|
$26,200 | — | 30 Jun 2024 | |
| BNP PARIBAS FINANCIAL MARKETS |
13F
|
Company |
—
class O/S missing
|
5,543
|
$22,615 | — | 30 Jun 2024 | |
| ACADIAN ASSET MANAGEMENT LLC |
13F
|
Company |
—
class O/S missing
|
5,440
|
$22,000 | — | 30 Jun 2024 | |
| US BANCORP \DE\ |
13F
|
Company |
—
class O/S missing
|
4,500
|
$18,360 | — | 30 Jun 2024 | |
| Tower Research Capital LLC (TRC) |
13F
|
Company |
—
class O/S missing
|
4,375
|
$17,850 | — | 30 Jun 2024 | |
| Corebridge Financial, Inc. |
13F
|
Company |
—
class O/S missing
|
3,395
|
$13,886 | — | 30 Jun 2024 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
—
class O/S missing
|
3,295
|
$13,444 | — | 30 Jun 2024 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
—
class O/S missing
|
2,689
|
$10,971 | — | 30 Jun 2024 | |
| Point72 (DIFC) Ltd |
13F
|
Company |
—
class O/S missing
|
2,295
|
$9,364 | — | 30 Jun 2024 | |
| BARCLAYS PLC |
13F
|
Company |
—
class O/S missing
|
2,166
|
$8,838 | — | 30 Jun 2024 | |
| UBS Group AG |
13F
|
Company |
—
class O/S missing
|
2,158
|
$8,804 | — | 30 Jun 2024 |
Institutional Holders of Metagenomi Therapeutics, Inc. - COM (MGX) as of Q3 2024
As of 30 Sep 2024,
Metagenomi Therapeutics, Inc. - COM (MGX) was held by
65 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
11,662,818 shares.
The largest 10 holders included
Novo Holdings A/S, RA CAPITAL MANAGEMENT, L.P., FARALLON CAPITAL MANAGEMENT LLC, PFM Health Sciences, LP, CITADEL ADVISORS LLC, HHLR ADVISORS, LTD., Sozo Ventures GP II, L.P., BlackRock, Inc., MILLENNIUM MANAGEMENT LLC, and VANGUARD GROUP INC.
This page lists
65
institutional shareholders reporting positions in this security
for the Q3 2024 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q3 2024 vs Q2 2024 Across Filers
Q2 2024 holders
54
Q3 2024 holders
65
Holder diff
11
| Investor | Q2 2024 Shares | Q3 2024 Shares | Share Diff | Share Chg % | Q2 2024 Value $ | Q3 2024 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.